Extraesophageal GERD

Gastroenterology Clinics of North America

Volumn 37, Issue 4, 2008, Pages 845-858

  Frye, Jeanetta Walters ^a   Vaezi, Michael F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acid suppression; Diagnostic testing; GERD; Laryngitis

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

ASTHMA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COUGHING; DRUG COST; DRUG MEGADOSE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HUMAN; LARYNGOPHARYNGEAL REFLUX; PH MEASUREMENT; REFLUX ASTHMA SYNDROME; REFLUX CHEST PAIN SYNDROME; REFLUX COUGH SYNDROME; REFLUX ESOPHAGITIS; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH PH; THORAX PAIN;

ASTHMA; CHEST PAIN; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGITIS; SYNDROME;

EID: 56349139590     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2008.09.005     Document Type: Review

References (69)

1. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease. Am J Gastroenterol 101 (2006) 1900-1920
2. Stanghellini V. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in the general population: results from The Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl 231 (1999) 29-37
3. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54 (2005) 710-717
4. Prado J., and Moraes-Filho P. Gastro-esophageal reflux disease: prevalence and management in Brazil. Best Pract Res Clin Gastroenterol 18 (2004) 23-26
5. Bor S., Mandiracioglu A., Kitapcioglu G., et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol 100 (2005) 759-765
6. Klauser A.G., Schindlbeck N.E., and Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet 335 (1990) 205-208
7. Berstad A., and Hatlebakk J.G. The predictive value of symptoms in gastro-oesophageal reflux disease. Scand J Gastroenterol Suppl 211 (1995) 1-4
8. Cicala M., Emerenziani S., Caviglia R., et al. Intraoesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 125 (2003) 605-613
9. Field S.K., Evans J.A., and Price L.M. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med 157 (1998) 1058-1062
10. Ing A.J., Ngu M.C., and Breslin A.B. Pathogenesis of chronic persistent cough associated with gastro-esophageal reflux. Am J Respir Crit Care Med 149 (1994) 160-167
11. Adhami T., Goldblum J.R., Richter J.E., et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 99 (2004) 2098-2106
12. Tuchman D.N., Boyle J.T., Pack A.I., et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 87 (1984) 872-881
13. Tokayer A.Z. Gastroesophagel reflux disease and chronic cough. Lung 186 Supple (2008) S29-S34
14. Poe R.H., and Kallay M.C. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123 (2003) 679-684
15. Irwin R.S. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinically practice guidelines. Chest 129 1 Suppl (2006) 80S-94S
16. Johnson D.A. Medical therapy of reflux laryngitis. J Clin Gastroenterol 42 (2008) 589-593
17. Vaezi M.F. Extraesophageal manifestations of gastroesophageal reflux disease. Clin Cornerstone 5 (2003) 32-38
18. Ours T.M., Kavuru M.S., Schilz R.J., et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94 (1999) 3131-3138
19. Schappert S.M. National ambulatory medical care survey, 1991: Summary. Vitals and Health Statistics No. 230. US Department of Health and Human Services (1993) 1-20
20. Baldi F., Cappiello R., Cavoli C., et al. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. World J Gastroenterol 12 1 (2006) 82-88
21. Irwin R.S., Correo W.M., and Pratter M.R. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful response to specific therapy. Am Rev Respir Dis 123 (1981) 413-417
22. Laukka M.A., Cameron A.J., and Schei A.J. Gastroesophageal reflux and chronic cough: which comes first?. J Clin Gastroenterol 19 (1994) 199-204
23. Everett C.F., and Morice A.H. Clinical history in gastroesophageal cough. Respir Med 101 (2007) 345-348
24. Chandra K.M.D., and Harding S.M. Therapy insight: treatment of gastroesophageal reflux in adults with chronic cough. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 604-613
25. Irwin R.S., Curley F.J., and French C.L. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation and outcome of specific therapy. Am Rev Respir Dis 141 (1990) 640-647
26. Irwin R.S., French C.L., Curley F.J., et al. Chronic cough due to gastroesophageal reflux: clinical, diagnostic and pathogenetic aspects. Chest 104 (1993) 1511-1517
27. McGarvey L.P., Heaney L.G., Lawson J.T., et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 53 (1998) 738-743
28. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 S53 (1991) 1-78
29. Vaezi M.F. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests?. Am J Gastroenterol 99 (2004) 786-788
30. Diamond L. Laryngopharyngeal reflux-it's not GERD: before you can alleviate symptoms in patients with LPR and ensure healing of the laryngopharynx, you must understand the differences between LPR and GERD. JAAPA 18 (2005) 50-53
31. Joniau S., Bradshaw A., Esterman A., et al. Reflux laryngitis: a systematic review. Otolaryngol Head Neck Surg 136 (2007) 686-692
32. Vaezi M.F. Laryngeal signs and symptoms of gastroesophageal reflux disease: a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 1 (2003) 222-244
33. Vaezi M. Reproducibility of proximal probe pH parameters in 24 hour ambulatory esophageal pH monitoring. Am J Gastroenterol 92 (1997) 825-829
34. Tack J., and Fass R. Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?. Aliment Pharmacol Ther 19 Suppl 1 (2004) 28-34
35. Malhotra A., Freston J.W., and Aziz K. Use of pH impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease. J Clin Gastroenterol 42 (2008) 271-278
36. Vaezi M.F. Are there specific laryngeal signs for gastroesophageal reflux disease?. Am J Gastroenterol 102 (2007) 723-724
37. Delahunty J.E., and Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope 78 (1968) 1941-1947
38. Vavricka S.R., Storck C., Wildi S.M., et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol 102 (2007) 716-722
39. Kamel P.L., Hanson D., and Kahrilas P.J. Omeprazole for the treatment of posterior laryngitis. Am J Med 96 (1994) 321-326
40. Vaezi M.F., Richter J.E., Stasney C.R., et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116 (2006) 254-260
41. Qadeer M.A., Phillips C.O., Lopez A.R., et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol 101 (2006) 2646-2654
42. Patel S.M., Stason W.B., Legedza A., et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 17 (2005) 332-340
43. Havemann B.D., Henderson C.A., and El-Serag H.B. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 56 (2007) 1654-1664
44. Kiljander T.O., Salomaa E.M., Hietanen E.K., et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 116 (1999) 1257-1264
45. Ahmed T. The role of pH monitoring in extraesophagael gastroesopageal reflux disease. Gastrointest Endosc Clin N Am 15 (2005) 319-331
46. Meier J.H., McNally P.R., Punja M., et al. Does omeprazole (Prilosec) improve respiratory function in asthmatics with gastroesophageal reflux? A double-blind, placebo-controlled crossover study. Dig Dis Sci 39 (1994) 2127-2133
47. Leggett J.L., Johnston B.T., Mills M., et al. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 127 (2005) 1227-1231
48. Sontag S.J., O'Connell S., Khandelwal S., et al. Asthmatic with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol 98 (2003) 987-999
49. Littner M.R., Leun F.W., Ballard E.D., et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 128 (2005) 1128-1135
50. Gibson PG. Gastroesophageal reflux treatment for asthma in adults and children. Cochrane Review (3). Oxford: update Software. 2002.
51. Kiljander T.O., Harding S.M., Field S.K., et al. Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 173 10 (2006) 1091-1097
52. Fass R., and Navarro-Rodriguez. Noncardiac chest pain. J Clin Gastroenterol 42 (2008) 636-646
53. Fang J., and Bjorkman D. A critical approach to noncardiac chest pain: pathophysiology, diagnosis and treatment. Am J Gastroenterol 96 (2001) 958-968
54. Schoenfield P., Bennett D., Whorwell P., et al. Exertional gastro-oesophageal reflux: a mechanism for symptoms in patients with angina pectoris and normal coronary angiograms. Br Med J 294 (1987) 1459-1461
55. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 112 (1997) 1448-1456
56. Alban-Davies H., Jones D., Rhoades J., et al. Angina-like esophageal pain: differentiation from cardiac pain from history. J Clin Gastroenterol 7 (1985) 477-481
57. Mousavi S., Tosi J., Eskandarian R., et al. Role of clinical presentation in diagnosing reflux-related noncardiac chest pan. J Gastroenterol Hepatol 22 (2007) 218-221
58. Wang W.H., Huang J.W., Zheng G.F., et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?. Arch Intern Med 165 (2005) 1222-1228
59. Lacima G., Grande L., Pera M., et al. Utility of ambulatory 24-hour esophageal pH and motility monitoring in noncardiac chest pain: report of 90 patients and review of the literature. Dig Dis Sci 48 (2003) 952-961
60. Breumelhof R., Nadorp J.H., Akkermans L.M., et al. Analysis of 24-hour esophageal pressure and pH data in unselected patients with noncardiac chest pain. Gastroenterology 99 (1990) 1257-1264
61. Cherian P., Smith L., Bardham K., et al. Esophageal tests in the evaluation of non-cardiac chest pain. Dis Esophagus 8 (1995) 129-133
62. Hsia P.C., Maher K.A., Lewis J.H., et al. Utility of upper endoscopy in the evaluation of noncardiac chest pain. Gastrointest Endosc 37 (1991) 22-26
63. Frobert O., Funch-Jensen P., Jacobsen N.O., et al. Upper endoscopy in patients with angina and normal coronary angiograms. Endoscopy 27 (1996) 365-370
64. Bautista J., Fullerton H., Brieseno M., et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled crossover trial. Aliment Pharmacol Ther 19 (2004) 1123-1130
65. Dickman R., Mattek N., Holub J., et al. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related Symptoms: results form a national endoscopic database. Am J Gastroenterol 102 (2007) 1173-1179
66. Achem S.R., Kolts B.E., MacMath T., et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 42 (1997) 2138-2145
67. Pandek W.M., Arezo S., Everett S., et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry or 24-hour esophageal pH monitoring. J Clin Gastroenterol 35 (2002) 307-314
68. Fass R., Fennerty M.B., Ofman J.J., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 115 (1998) 42-49
69. Ofman J.J., Grainek I.M., Udani J., et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 107 (1999) 219-227